Author

Piergiorgio Malagoli

Observed names: Malagoli P, Malagoli Piergiorgio, Malagoli, P, Malagoli, P., Malagoli, Piergiorgio, P Malagoli, P. Malagoli, PG Malagoli, Perigiorgio Malagoli, Piergiorgio MALAGOLI, Piergiorigio Malagoli, Pierglorgio Malagoli

Institution: IRCCS Policlinico San Donato

Observed institutions: Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Centro Studi GISED, University of Milan, University of Campania "Luigi Vanvitelli", University of Pavia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, IRCCS Policlinico San Donato, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Policlinico San Matteo Fondazione, University of Naples Federico II

ORCID: 0000-0002-6181-6922

Observed ORCID: 0000-0002-6181-6922

OpenAlex ID: A5028135237

The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

2020 · P. Gisondi, P. Facheris, et al. · British Journal of Dermatology · 114

PDF

Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration

2020 · Giovanni Damiani, Alessia Pacifico, et al. · Dermatologic Therapy · 111

PDF

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature

2020 · G. Caldarola, F. Pirro, et al. · Expert Opinion on Biological Therapy · 100

The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study

2019 · Mohammad Adawi, Giovanni Damiani, et al. · Nutrients · 91

PDF

The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter Study

2019 · Giovanni Damiani, Abdulla Watad, et al. · Nutrients · 84

PDF

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations

2021 · Paolo Gisondi, Marina Talamonti, et al. · Dermatology and Therapy · 82

PDF

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)

2023 · Luigi Gargiulo, Alessandra Narcisi, et al. · Frontiers in Medicine · 68

PDF

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)

2024 · Luigi Gargiulo, Luciano Ibba, et al. · Frontiers in Immunology · 65

PDF

Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients

2017 · M. Talamonti, M. Galluzzo, et al. · British Journal of Dermatology · 62

Vitiligo Is Associated with a Significant Increase in HLA-A30, Cw6 and DQw3 and a Decrease in C4AQ0 in Northern Italian Patients

2009 · G. Orecchia, L. Perfetti, et al. · Dermatology · 61

COVID ‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration

2020 · Nicola Luigi Bragazzi, Matteo Riccò, et al. · Dermatologic Therapy · 59

PDF

The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting (“Ramadan Fasting”) on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study

2019 · Giovanni Damiani, Naim Mahroum, et al. · Nutrients · 56

PDF

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience

2020 · Paolo Gisondi, Stefano Piaserico, et al. · Journal of Allergy and Clinical Immunology · 55

PDF

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— IL PSO ( Italian landscape psoriasis )

2022 · Alessandra Narcisi, Mario Valenti, et al. · Journal of the European Academy of Dermatology and Venereology · 53

PDF

Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes

2023 · Alexis Elias Malavazos, Chiara Meregalli, et al. · Endocrinology Diabetes and Metabolism Case Reports · 52

PDF

Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study

2019 · Tiago Torres, Anna Balato, et al. · Journal of the American Academy of Dermatology · 52

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis

2015 · Marco Galluzzo, Andreea Nicoleta Boca, et al. · Dermatology · 49

Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study

2019 · Andrea Chiricozzi, Martina Burlando, et al. · American Journal of Clinical Dermatology · 48

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

2021 · Riccardo G. Borroni, Piergiorgio Malagoli, et al. · Acta Dermato Venereologica · 47

PDF

COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers

2021 · G. Damiani, F. Allocco, et al. · Clinical and Experimental Dermatology · 47

PDF

When IL‐17 inhibitors fail: Real‐life evidence to switch from secukinumab to adalimumab or ustekinumab

2018 · Giovanni Damiani, Rosalynn R. Z. Conic, et al. · Dermatologic Therapy · 46

PDF

Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience

2018 · A. Conti, F. Peccerillo, et al. · British Journal of Dermatology · 45

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)

2024 · Diego Orsini, Piergiorgio Malagoli, et al. · Dermatology Practical & Conceptual · 44

PDF

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

2019 · Andrea Chiricozzi, Anna Balato, et al. · Journal of Dermatological Treatment · 44

PDF

Treatment of Severe Alopecia Areata with Squaric Acid Dibutylester in Pediatric Patients

1994 · Giovanni Orecchia, Pierglorgio Malagoli, et al. · Pediatric Dermatology · 40

Works count: 138

Citation count: 2,770

H-index: 32

I10-index: 71